fMRI activation in the amygdala and the orbitofrontal cortex in unmedicated subjects with major depressive disorder

Jennifer D Townsend1, Nicole K Eberhart, Susan Y Bookheimer

  • 1Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, and Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA.

Psychiatry Research
|August 17, 2010
PubMed

Insights

Major depressive disorder (MDD) patients and healthy controls showed similar amygdala and prefrontal cortex activation during an emotional task. Unmedicated MDD subjects did not exhibit significant differences in fronto-limbic region function compared to controls.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Cognitive Psychology

Background:

  • Functional abnormalities in the amygdala and frontal lobe are reported in mood disorders, but findings in major depressive disorder (MDD) are inconsistent.
  • Potential confounds include sample heterogeneity, medication status, and analytical methods.
  • Previous research on unmedicated subjects suggests no significant differences in amygdala function in depression during simple emotion observation tasks.

Purpose of the Study:

  • To evaluate amygdala and frontal lobe activation in unmedicated patients with major depressive disorder (MDD).
  • To investigate potential differences in brain activation between MDD patients and healthy controls during an emotional face task.
  • To examine correlations between clinical features and brain activation in MDD patients.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) was used to scan 15 unmedicated MDD patients and 15 matched healthy controls.
  • Participants performed an emotional face task designed to activate the amygdala and prefrontal cortex (PFC).
  • Whole-brain and region of interest analyses were conducted, alongside correlations between clinical symptoms and activation levels.

Main Results:

  • Both MDD patients and controls demonstrated significant activation in the amygdala and lateral PFC.
  • Between-group comparisons revealed reduced activation in the insula, temporal, and occipital cortices in MDD patients.
  • Anxiety symptoms in MDD were associated with decreased orbitofrontal cortex activation.
  • No significant between-group differences in fronto-limbic activation were found using either analytical approach.

Conclusions:

  • This study replicates findings of no significant differences in amygdala function between unmedicated MDD subjects and controls during simple emotion observation.
  • Despite group differences in other cortical regions, core fronto-limbic activation during this task remains comparable.
  • These results contribute to understanding the neural underpinnings of MDD, emphasizing the need for careful consideration of confounds like medication status.